Skip to Content

C533 (Tenofovir Disoproxil Fumarate 300 mg)

Pill with imprint C533 is Blue, Capsule-shape and has been identified as Tenofovir Disoproxil Fumarate 300 mg. It is supplied by Cipla USA Inc..

Tenofovir is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C533

Tenofovir disoproxil fumarate 300 mg C533

Tenofovir Disoproxil Fumarate

Imprint
C533
Strength
300 mg
Color
Blue
Size
17.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0533
Inactive Ingredients
lactose monohydrate, croscarmellose sodium, corn starch, polysorbate 80, microcrystalline cellulose, magnesium stearate, titanium dioxide, triacetin, FD&C Blue No. 2, hypromellose 2910 (15 mPa.s)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.